TRENTON, NJ | June 24, 2020
The American Lung Association is taking action to address the COVID-19 pandemic and prepare our nation for future respiratory diseases with Award-winning actress Laura Dern and CVS Health. From June 21-July 18, 2020, anyone can donate at their local CVS Pharmacy® or online to support the Lung Association’s new COVID-19 Action Initiative. The initiative will invest $25 million over three years to expand COVID-19 research, increase access to vaccines and antivirals and prevent future respiratory pandemics.
Since the beginning of the COVID-19 pandemic, New Jersey has sadly reported 169,415 active cases and 12,895 deaths as of June 23, 2020. The initiative will also support 970,000 New Jersey residents living with a lung disease who are at high risk for complications from the virus.
“COVID-19 has had a devastating impact on our communities, including those who are more vulnerable to the impacts of the disease, such as older adults, Black and Hispanic communities, and the 970,000 New Jersey residents who are living with a lung disease such as asthma or COPD,” said Karen Isky, senior development director of the American Lung Association in New Jersey. “To save more lives, it will take everyone coming together, and we’re proud to stand alongside Laura Dern and CVS Health to raise funds for lifesaving research.”
Dern is best known for her work in films such as Jurassic Park, Wild and in series including Showtime’s Twin Peaks and more recently HBO’s Big Little Lies. She recently won the Academy Award, Golden Globe and SAG Award for Best Supporting Actress for her role in Marriage Story.
“I am partnering with the American Lung Association and CVS Health so that we can give hope to everyone who would normally be vulnerable to infection, and prevent others from losing their loved ones,” said Dern. “If we come together, I know we can make a positive impact in the lives of the millions of people impacted by this terrible disease.” See Dern’s video here.
Funds raised through the CVS Health campaign will allow the Lung Association to expand COVID-19 research within the current studies of their Airways Clinical Research Centers (ACRC) Network, as well as new coronavirus awards and grants to advance knowledge for preventive research, vaccines, antivirals and to advance future outbreak preparedness. The initiative will also enhance key public health measures through education and advocacy, and establish an advanced network of government, private industry and public health organizations to stop future respiratory virus pandemics.
As a long-time partner of the American Lung Association, CVS Health has signed on as a leading sponsor of their COVID-19 Action Initiative. In addition to hosting the in-store fundraising campaign, CVS Health is now providing drive-thru COVID-19 testing at CVS Pharmacy locations in New Jersey. These tests are being offered at no-cost to improve access and necessary care for historically underserved communities.
For more information on the COVID-19 Action Initiative, visit Lung.org/covid-19. Journalists seeking to schedule an interview with a lung health expert may contact Valerie Gleason at 717-971-1123 or [email protected].
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Platinum-Level GuideStar Member, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org. To support the work of the American Lung Association, find a local event at Lung.org/events.
We urgently need your help against Big Tobacco!
Saving lives starts by ending the sale of menthol cigarettes and all flavored cigars. Join us in urging the White House to finalize these rules before the end of the year.